Related Experiment Video
Updated: Oct 3, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Mechanisms of tolerance to DNA damaging therapeutic drugs
1Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hertfordshire, EN6 3LD, UK. karran@icrf.icnet.uk
Abstract:
The cytotoxic effect of many anticancer drugs relies on their ability to damage DNA. Drug resistance can be associated with the ability to remove potentially lethal DNA lesions. DNA damage tolerance offers an alternative route to resistance. In a drug-tolerant cell, persistent DNA damage has become uncoupled from cell death. Tolerance to some DNA damaging drugs is accompanied by inactivation of the cell's DNA mismatch repair pathway. This is widely acknowledged as the mechanism underlying resistance to methylating agents and to 6-thioguanine which produce structurally similar types of DNA damage. Defects in mismatch repair are also associated with resistance to numerous drugs that produce a wide variety of structurally diverse DNA lesions. Here I consider possible mechanisms by which mismatch repair might influence drug resistance and the extent to which loss of mismatch repair might be considered to confer a multidrug resistance phenotype.
Insights
Drug resistance can occur when cells tolerate DNA damage, bypassing cell death. Inactivation of the DNA mismatch repair pathway is linked to this tolerance and may confer multidrug resistance.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Anticancer drugs often induce cytotoxicity by damaging DNA.
- Drug resistance can arise from mechanisms that repair or tolerate DNA lesions.
- DNA damage tolerance represents a pathway where cells survive persistent DNA damage.
Purpose of the Study:
- To explore how DNA mismatch repair (MMR) influences drug resistance.
- To determine if loss of MMR function confers a multidrug resistance phenotype.
Main Methods:
- Review of existing literature on DNA damage, drug resistance, and MMR.
- Analysis of mechanisms linking MMR inactivation to tolerance of DNA damaging agents.
Main Results:
- Tolerance to certain DNA damaging drugs correlates with MMR pathway inactivation.
- MMR deficiency is a known mechanism for resistance to methylating agents and 6-thioguanine.
- Defects in MMR are associated with resistance to a diverse range of DNA-damaging drugs.
Conclusions:
- Inactivation of the DNA mismatch repair pathway is a key factor in drug tolerance and resistance.
- Loss of MMR function may contribute to a broad multidrug resistance phenotype, impacting sensitivity to various anticancer agents.
Related Concept Videos
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Chemically...
Treatment Resistant Cancers
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair